HomeIndustriesHealthcareEli Lilly (LLY) Might Not Meet Demand for Diabetes & Weight Loss Drugs

Eli Lilly (LLY) Might Not Meet Demand for Diabetes & Weight Loss Drugs

Eli Lilly (LLY) will likely not meet the demand for diabetes and weight loss drugs in 2024. The Eli Lilly CFO noted that increases in production capacity will take time. Eli Lilly is up over 150% year-over-year. Tune in to find out more about the stock market today.

Market On Close

06 Mar 2024

SHARE

ON AIR
education
6:00 am
Schwab 2026 Outlook
replay
education
12:00 am
Schwab 2026 Outlook
REPLAY
1:00 am
Market Overtime
REPLAY
education
2:00 am
Your First Trade
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Market Overtime
REPLAY
4:30 am
Market Overtime
REPLAY
5:00 am
Market Overtime
REPLAY
5:30 am
Market Overtime
REPLAY
ON AIR
education
6:00 am
Schwab 2026 Outlook
REPLAY
7:00 am
Market Overtime
REPLAY
education
8:00 am
Your First Trade
REPLAY
education
8:30 am
Your First Trade
REPLAY
9:00 am
Fast Market
REPLAY
10:00 am
Market Overtime
REPLAY
10:30 am
Market Overtime
REPLAY
11:00 am
Market Overtime
REPLAY
11:30 am
Market Overtime
REPLAY
education
12:00 pm
Schwab 2026 Outlook
REPLAY
1:00 pm
Market Overtime
REPLAY
education
2:00 pm
Your First Trade
REPLAY
education
2:30 pm
Your First Trade
REPLAY
3:00 pm
Fast Market
REPLAY
4:00 pm
Market Overtime
REPLAY
4:30 pm
Market Overtime
REPLAY
5:00 pm
Market Overtime
REPLAY
5:30 pm
Market Overtime
REPLAY
education
6:00 pm
Schwab 2026 Outlook
REPLAY
7:00 pm
Market Overtime
REPLAY
education
8:00 pm
Your First Trade
REPLAY
education
8:30 pm
Your First Trade
REPLAY
9:00 pm
Fast Market
REPLAY
10:00 pm
Market Overtime
REPLAY
10:30 pm
Market Overtime
REPLAY
11:00 pm
Market Overtime
REPLAY
11:30 pm
Market Overtime
REPLAY

Schwab Network's Newsletters

Daily insights for every investor